We have located links that may give you full text access.
Stationary afterglow apparatus with CRDS for study of processes in plasmas from 300 K down to 30 K.
Review of Scientific Instruments 2018 June
A cryogenic stationary afterglow apparatus equipped with a near-infrared cavity-ring-down-spectrometer (Cryo-SA-CRDS) for studies of electron-ion recombination processes in the plasma at temperatures 30-300 K has been designed, constructed, tested, and put into operation. The plasma is generated in a sapphire discharge tube that is contained in a microwave cavity. The cavity and the tube are attached to the second stage of the cold head of the cryocooler system, and they are inserted to an UHV chamber with mirrors for CRDS and vacuum windows on both ends of the tube. The temperature of the discharge tube can be made as low as 25 K. In initial test measurements, the discharge was ignited in He/Ar/H2 or He/H2 gas mixtures and the density of H3 + ions and their kinetic and rotational temperatures were measured during the discharge and afterglow. From the measured decrease in the ion density, during the afterglow, effective recombination rate coefficients were determined. Plasma relaxation was studied in He/Ar gas mixtures by monitoring the presence of highly excited argon atoms. The spectroscopic measurements demonstrated that the kinetic temperature of the ions is equal to the gas temperature and that it can be varied from 300 K down to 30 K.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app